Updates

Dr Maria Koufali, Head of the Vaccine Innovation Pathway, outlines how the NIHR are expanding the UK's vaccine research potential to support the development of future vaccines in a post in the NIHR's blog.

Sponsors and sites have both escalated challenges and delays associated with setting up cancer vaccine studies. In response, the VIP analysed all the feedback and developed a guidance document to support the effective set up of mRNA cancer vaccine studies. Click here to view or download the document, along with an ATMP Setup Checklist and an ATMP IMP Handling document for sponsors.